000			03280nam a22004095i 4500
001			86567
003			ES-MaUEC
005			20230207040604.0
007			cr nn 008mamaa
008			151001s2016 ja | s |||| 0|eng d
020			_a9784431555223
040			_aES-MaUEC
050		4	_aRC280.C6 _b2016 EB
082	0	4	_a617
245	0	0	_aColitis-associated cancer _cedited by Masato Kusunoki
250			_a1st ed.
260			_aTokyo _bSpringer _c2016
300			_a1 recurso en línea (VIII, 150 p.) _b21 ilustraciones, 15 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aChapter 1 Colitis-Associated Cancer: Overview -- Part I Clinical Features -- Chapter 2 Incidence and Risk Factors -- Chapter 3 Prevention and Prognosis -- Part II. Diagnosis -- Chapter 4 Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease -- Chapter 5 Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer -- Part III. Surgical Treatment -- Chapter 6 Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia -- Chapter 7 Surgical Treatment for Colorectal Cancer in Crohn's Disease
520			_aAs the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn's disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aColon _xCáncer _9182269 _0comprobar BNE19901350818 _2embne
650		7	_aCáncer _xInvestigación _0comprobar BNE19901364217 _2embne _9182523
650		7	_aGenética médica _0comprobar BNE19913258705 _2embne _9144879
650		7	_aEnteritis regional _9146594 _0comprobar BNE19923778779 _2embne
700	1		_aKusunoki, Masato _eeditor literario _9100382 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-4-431-55522-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9784431555223
907			_a.b12958451 _b10-10-17 _c21-11-16
988			_aSpringer_Medicine_2016
998			_am _a_alco _a_vill _b07-06-17 _cm _dz _eb _feng _gja _h0
945			_aRC280 .C6 C65 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11600056 _z06-04-17
999			_c86567 _d86567 _x1